First-in-Humans PET Imaging of KRASG12C Mutation Status in Non-Small Cell Lung and Colorectal Cancer Patients Using [18F]PFPMD

Conclusion: [18F]PFPMD is a safe and promising PET tracer for noninvasive screening of the KRASG12C mutation status in NSCLC and CRC patients.

Source: Journal of Nuclear Medicine - December 1, 2023 Category: Nuclear Medicine Authors: Li, X., Ye, J., Wang, J., Quan, Z., Li, G., Ma, W., Zhang, M., Yang, W., Wang, J., Ma, T., Kang, F., Wang, J. Tags: Clinical Investigations Source Type: research